Guido Eibl
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 28
- Cancer Research top 2%
- Surgery top 2%
- Pancreatitis Pathology and Treatment 28
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer 14
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects 16
-
- Electrolyte and hormonal disorders 9
-
- Renal function and acid-base balance 8
-
- Cancer, Stress, Anesthesia, and Immune Response 8
-
- Estrogen and related hormone effects 8
- Co-authors
- O. Joe HinesHoward A. ReberEnrique RozengurtJames Sinnett‐SmithKrisztina KisfalviJohn P. DuffyH. J. BuhrAune Moro
- Cited by
- OncologyCancer ResearchSurgery
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Guido Eibl
100 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 2.0k
- Cancer Research 839
- Surgery 1.2k
- Molecular Biology 1.8k
- Pharmacology 369
Countries citing papers authored by Guido Eibl
This map shows the geographic impact of Guido Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Eibl more than expected).
Fields of papers citing papers by Guido Eibl
This network shows the impact of papers produced by Guido Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Eibl. The network helps show where Guido Eibl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guido Eibl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 10 | |
| 4 | 2020 | 3 | |
| 5 | 2019 | 18 | |
| 6 | 2019 | 41 | |
| 7 | 2018 | 44 | |
| 8 | 2018 | 32 | |
| 9 | 2017 | 104 | |
| 10 | 2014 | 24 | |
| 11 | 2013 | 74 | |
| 12 | 2010 | 20 | |
| 13 | 2009 | 258 | |
| 14 | 2008 | 26 | |
| 15 | 2005 | 86 | |
| 16 | 2002 | 24 | |
| 17 | 2001 | 15 | |
| 18 | 2000 | 26 | |
| 19 | 1999 | 54 | |
| 20 | [Value of magnetic resonance tomography in preoperative staging of stomach carcinoma]. | 1998 | 1 |
About Guido Eibl
Guido Eibl is a scholar working on Oncology, Cancer Research and Nephrology, having authored 102 papers that have together received 4.1k indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (28 papers), Pancreatic and Hepatic Oncology Research (28 papers), Inflammatory mediators and NSAID effects (16 papers), Metabolism, Diabetes, and Cancer (14 papers), Electrolyte and hormonal disorders (9 papers), Renal function and acid-base balance (8 papers), Cancer, Stress, Anesthesia, and Immune Response (8 papers) and Estrogen and related hormone effects (8 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (839 citations) and Surgery (1.2k citations). Guido Eibl has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include O. Joe Hines, Howard A. Reber, Enrique Rozengurt, James Sinnett‐Smith, Krisztina Kisfalvi, John P. Duffy, H. J. Buhr, Aune Moro, Hui-Hua Chang and Hubert G. Hotz. Their work appears in journals such as Pancreas, Cancer Research, Surgery, PLoS ONE and American Journal of Physiology-Gastrointestinal and Liver Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.